Results 131 to 140 of about 2,142 (195)

A Randomized, Open-Label, Single-Dose, Parallel-Group Bioequivalence Study of Ferric Carboxymaltose Injection Under Fasting Conditions in Chinese Adult Subjects With Iron Deficiency Anemia. [PDF]

Pharmacol Res Perspect
Gong F, Hu S, Yuan J, Song J.
europepmc   +1 more source

Global research trends in renal anemia: a multidimensional bibliometric study. [PDF]

Ren Fail
Niu Y, Wang Y, Huo C, Fang Y.
europepmc   +1 more source

INDEPSO-ISPSM consensus on peritoneal malignancies - Enhanced recovery after surgery in cytoreductive surgery (CRS) with/without hyperthermic intraperitoneal chemotherapy (HIPEC). [PDF]

Gynecol Oncol Rep
Prakash Bhandoria G, Guru A, Pawar A, Bhatt A, Kumar N, Kumar R, Patel S, Lal Solanki S, Sukumar V, Rajagopal AK, Somashekhar SP.   +10 more
europepmc   +1 more source

Association between serum hepcidin-25 levels and hyporesponsiveness to erythropoiesis-stimulating agents in Japanese patients receiving hemodialysis: a cross-sectional study. [PDF]

Clin Exp Nephrol
Fujikawa R, Nagano N, Mitobe Y, Ito K.
europepmc   +1 more source

Erythropoiesis-Stimulating Agents and Development of Cancer Among Patients Receiving Dialysis.

JAMA Netw Open
Kim JY, Lee JK, Chang TI, Kim HW.
europepmc   +1 more source

Quantitative determination of iron (III) in polymaltose haematinic formulations on the Ghanaian market. [PDF]

PLoS One
Okwampah R, Bedzra KD, Gyamfi OK, Ataki J, Kyei F, Adarkwah-Yiadom M, Sosu E, Boateng E.   +7 more
europepmc   +1 more source

Efficacy and safety of Ferrous iron on the prevention of Vascular cOgnitive impaiRment among patients with cerebral Infarction/TIA (FAVORITE): rationale and design of a multicentre randomised trial. [PDF]

Stroke Vasc Neurol
Jia Q, Lei P, Sun L, Jia WL, Pan Y, Yuan B, Wang Y, Zhou Q, Meng X, Jing J, Lin J, Wang A, Zhang S, Hong Z, Yang Y, Xiong Y, Li Z, Wang Y, Zhao X, Wang Y.   +19 more
europepmc   +1 more source

Low sirtuin-1 levels are linked to erythropoietin resistance in hemodialysis patients. [PDF]

Ren Fail
Hekimgil E, Gul CB.
europepmc   +1 more source

Erythropoiesis-Stimulating Agent Protects Against Kidney Fibrosis by Inhibiting G2/M Cell Cycle Arrest. [PDF]

Cells
Oh D, Jhee JH, Kim SH, Kim TY, Kim HJ, Bae W, Choi HY, Park HC.   +7 more
europepmc   +1 more source

Adherence to monitoring iron indices at the initiation of erythropoiesis-stimulating agents or hypoxia-inducible factor prolyl hydroxylase inhibitors. [PDF]

Clin Exp Nephrol
Miyamoto Y, Okada A, Sasabuchi Y, Nangaku M, Yasunaga H.   +4 more
europepmc   +1 more source